Monitoring glucose levels in pregnant women to improve gestational diabetes diagnosis
Official title: Integrated Continuous Glucose Monitoring Glycemic cHAracterization During Pregnancy in Comparison With OGTT (I-CHAP)
Run by KK Women's and Children's Hospital · NCT06357728 · Data updated 2026-11-12
This study is testing if using a continuous glucose monitor can help better diagnose gestational diabetes in pregnant women of Chinese and Indian descent.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 45 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | KK Women's and Children's Hospital Government |
| Locations | 1 site (Singapore, Singapore) |
| Status | Recruiting |
| Started | July 1, 2024 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT06357728 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women of Chinese or Indian ethnicity, aged 21-45 years, who are scheduled for an OGTT between 20-35 weeks of gestation.
✕Probably not a fit
Patients with pre-existing Type 1 or Type 2 diabetes, serious skin conditions, or mental illnesses that prevent informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of continuous glucose monitoring (CGM) to better diagnose gestational diabetes mellitus (GDM) in pregnant women of Chinese and Indian ethnicity. It aims to correlate CGM glucose values with traditional oral glucose tolerance test (OGTT) results and assess the impact of glucose variability on maternal and fetal outcomes. By focusing on a specific population in Singapore, the study seeks to provide valuable insights into the effectiveness of CGM in managing GDM and improving pregnancy outcomes. The research will involve a single-arm intervention where participants will wear a CGM device during their pregnancy.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of gestational diabetes, ultimately enhancing maternal and fetal health outcomes.
How similar studies have gone: While the use of CGM in pregnancy is gaining attention, this specific approach focusing on GDM diagnosis in an Asian population is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Pregnant women of only Chinese or Indian ethnicity 2. Pregnant women between age 21--45 years old 3. Oral glucose tolerance test (OGTT) to be scheduled between 20-35 weeks gestational age 4. OGTT to be done at KK Women's and Children's Hospital Exclusion Criteria: 1. Women with serious skin conditions (e.g. eczema) that precludes wearing the sensor for 10 days 2. Exclusion criteria were pre-existing Type 1 or Type 2 diabetes, mental illness precluding informed consent and women who were diagnosed early (1st or early 2nd trimester for GDM).
Where it's running
-
KK Women's and Children's Hospital
Singapore, Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Phaik Ling, Elaine Quah, PhD — KK Women's and Children's Hospital
- Study coordinator: Phaik Ling, Elaine Quah, PhD
- Email: quah.phaik.ling@kkh.com.sg
- Phone: 65 97732543
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Network for studying rare and atypical diabetes
This study is trying to find and understand rare types of diabetes by testing people and families who haven't been diagnosed yet, using blood tests and genetic screening to learn more about these conditions.
-
Cognitive-behavioral therapy and exercise training for teenage girls at risk for type 2 diabetes
This study is testing if cognitive-behavioral therapy, exercise training, or both can help teenage girls at risk for type 2 diabetes improve their health and reduce stress and depression.
-
Real-time continuous glucose monitoring for young adults at risk of DKA
This project will try a Dexcom G6 real-time continuous glucose monitor to see if it helps 18-25-year-olds with insulin-treated diabetes who have poor blood sugar control or recent hospital admissions for high blood sugar.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.